Quantum Healthcare Limited (SGX: V8Y)
Singapore
· Delayed Price · Currency is SGD 0.0020
0.00 (0.00%)
At close: Nov 11, 2024
Quantum Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 12.86 | 13.08 | 9.37 | - | 0.56 | 7.95 | Upgrade
|
| Revenue Growth (YoY) | 11.42% | 39.63% | - | - | -93.00% | -28.76% | Upgrade
|
| Cost of Revenue | 7.22 | 7.32 | 5.02 | - | 0.62 | 7.64 | Upgrade
|
| Gross Profit | 5.64 | 5.76 | 4.35 | - | -0.06 | 0.32 | Upgrade
|
| Selling, General & Admin | 9.03 | 8.73 | 6.61 | 3.26 | 3.44 | 4.28 | Upgrade
|
| Research & Development | - | - | 0.74 | - | 4.02 | 5.99 | Upgrade
|
| Other Operating Expenses | -0.18 | -0.18 | -0.09 | 0 | -0.39 | -0.61 | Upgrade
|
| Operating Expenses | 8.84 | 8.55 | 7.27 | 3.26 | 7.07 | 9.66 | Upgrade
|
| Operating Income | -3.2 | -2.79 | -2.92 | -3.26 | -7.13 | -9.34 | Upgrade
|
| Interest Expense | -0.43 | -0.49 | -0.45 | -0.03 | -0.28 | -0.25 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0 | -0.04 | -0.03 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -3.63 | -3.28 | -3.37 | -3.34 | -7.43 | -9.64 | Upgrade
|
| Impairment of Goodwill | - | - | -4.63 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.79 | 0.14 | -0.14 | - | Upgrade
|
| Asset Writedown | - | - | - | -2.11 | -0 | - | Upgrade
|
| Legal Settlements | 2 | - | - | - | - | - | Upgrade
|
| Pretax Income | -1.63 | -3.28 | -8.78 | -5.31 | -7.58 | -9.64 | Upgrade
|
| Income Tax Expense | 0.07 | 0.1 | 0.12 | - | 0 | - | Upgrade
|
| Earnings From Continuing Operations | -1.71 | -3.38 | -8.9 | -5.31 | -7.58 | -9.64 | Upgrade
|
| Minority Interest in Earnings | -0.13 | -0.24 | -0.17 | 0.03 | - | - | Upgrade
|
| Net Income | -1.83 | -3.62 | -9.07 | -5.28 | -7.58 | -9.64 | Upgrade
|
| Net Income to Common | -1.83 | -3.62 | -9.07 | -5.28 | -7.58 | -9.64 | Upgrade
|
| Shares Outstanding (Basic) | 7,673 | 7,327 | 6,751 | 2,260 | 2,171 | 2,171 | Upgrade
|
| Shares Outstanding (Diluted) | 7,673 | 7,327 | 6,751 | 2,260 | 2,171 | 2,171 | Upgrade
|
| Shares Change (YoY) | 8.97% | 8.53% | 198.73% | 4.08% | - | 6.16% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 0.61 | -0.93 | -2.23 | -1.3 | -6 | -8.11 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Gross Margin | 43.85% | 44.03% | 46.42% | - | -10.59% | 3.97% | Upgrade
|
| Operating Margin | -24.89% | -21.34% | -31.14% | - | -1279.53% | -117.46% | Upgrade
|
| Profit Margin | -14.25% | -27.68% | -96.78% | - | -1360.32% | -121.23% | Upgrade
|
| Free Cash Flow Margin | 4.75% | -7.08% | -23.76% | - | -1076.30% | -101.94% | Upgrade
|
| EBITDA | -2.66 | -2.31 | -2.59 | -3.17 | -7.06 | -9.24 | Upgrade
|
| EBITDA Margin | -20.65% | -17.68% | -27.62% | - | - | -116.12% | Upgrade
|
| D&A For EBITDA | 0.55 | 0.48 | 0.33 | 0.09 | 0.07 | 0.11 | Upgrade
|
| EBIT | -3.2 | -2.79 | -2.92 | -3.26 | -7.13 | -9.34 | Upgrade
|
| EBIT Margin | -24.89% | -21.34% | -31.14% | - | - | -117.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.